Mostrar el registro sencillo de la publicación

dc.contributor.authorCarreño, Gustavo
dc.contributor.authorPereira, Alfredo
dc.contributor.authorÁvila-Salas, Fabián
dc.contributor.authorMarican, Adolfo
dc.contributor.authorAndrade, Fernanda
dc.contributor.authorRoca-Melendres, Maria
dc.contributor.authorValdés, Oscar
dc.contributor.authorVijayakumar, Sekar
dc.contributor.authorSchwartz Jr, Simó
dc.contributor.authorAbasolo, Ibane
dc.contributor.authorRafael, Diana
dc.contributor.authorDurán-Lara, Esteban F.
dc.date.accessioned2022-08-24T16:32:03Z
dc.date.available2022-08-24T16:32:03Z
dc.date.issued2021
dc.identifier.urihttp://repositorio.ucm.cl/handle/ucm/4015
dc.description.abstractA rational design accurate based on the use of Statistical Design of the Experiments (DoE) and Molecular Dynamics Simulations Studies allows the prediction and the understanding of thermo-responsive hydrogels prepared regarding their gelation temperature and anti-cancer drug release rate. N-isopropylacrilamide (NIPAM) modified with specific co-monomers and crosslinkers, can be used to prepare “on-demand” thermo-responsive hydrogels with the ideal properties for clinical applications in which local sustained release of drugs is crucial. Two preferential formulations resulting from the predictive studies of DoE and In Silico methods were synthesized by radical polymerization, fully characterized, and loaded with the anticancer drug Doxorubicin (Dox). The hydrogel formulations were characterized by swelling rate, turbidity, FTIR, 1H NMR, SEM, gelation time, rheology, and biocompatibility assays. Both formulations demonstrated adequate morphologic, rheological, and biocompatibility properties; however, important differences in terms of drug retention were detected. As demonstrated by a Dox cumulative release study and posteriorly confirmed by an efficacy assay in an in vitro colorectal cancer model, the formulation composed by NIPAM and 4-penten-1-ol crosslinked with poly(ethylene glycol) diacrylate (PEGDA) (PNiPenPH) present a slow release over the time, presenting ideal properties to become and ideal depot system for the local sustained release of anticancer drugs as adjuvant therapy or in the case of non-resectable tumors.es_CL
dc.language.isoenes_CL
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
dc.sourceMaterials Science and Engineering: C, 131, 112483es_CL
dc.subjectThermo-responsive hydrogelses_CL
dc.subjectMolecular dynamics simulationses_CL
dc.subjectSustained releasees_CL
dc.subjectCancer treatmentes_CL
dc.subjectRheologyes_CL
dc.subjectStatistical design of experimentses_CL
dc.titleDevelopment of “on-demand” thermo-responsive hydrogels for anti-cancer drugs sustained release: rational design, in silico prediction and in vitro validation in colon cancer modelses_CL
dc.typeArticlees_CL
dc.ucm.indexacionScopuses_CL
dc.ucm.indexacionIsies_CL
dc.ucm.uriwww.sciencedirect.com/science/article/pii/S0928493121006238es_CL
dc.ucm.doidoi.org/10.1016/j.msec.2021.112483es_CL


Ficheros en la publicación

FicherosTamañoFormatoVer

No hay ficheros asociados a esta publicación.

Esta publicación aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo de la publicación

Atribución-NoComercial-SinDerivadas 3.0 Chile
Excepto si se señala otra cosa, la licencia de la publicación se describe como Atribución-NoComercial-SinDerivadas 3.0 Chile